Local Treatment Efficacy for Single-Area Squamous Cell Carcinoma of the Unknown Primary Site

Curr Oncol. 2023 Oct 20;30(10):9327-9334. doi: 10.3390/curroncol30100674.

Abstract

The prognosis for cancer of unknown primary site (CUP) is poor, and squamous cell carcinoma of the unknown primary site (SCCUP) is a rare histological type. CUP is often treated with aggressive multimodal treatments, while the treatment of single-area localized CUP remains controversial. We retrospectively reviewed the medical records of patients with CUP. SCCUP in women was classified according to several definitions. Based on the histologic type and site, they were classified into favorable and unfavorable subsets. We further divided SCCUP into two types (single and multiple areas) and reviewed treatment and efficacy. Among the 227 female CUP patients, 36 (15%) had SCCUP. The median age was 59.9 years (range, 31-90 years). Most patients (61.1%) had a good performance status. Of the SCCUP patients, 22 had cancer in a single area, and 14 in multiple areas. Single-area SCCUP was further divided into favorable (16 cases) and unfavorable subsets (6 cases). In the favorable subset, local treatment was predominant, and almost all cases had a good prognosis. Even in the unfavorable subset, local therapy was combined with systemic chemotherapy in only two cases, and four cases showed no recurrences. Local treatment may be effective for single-area SCCUP, even in the unfavorable subset.

Keywords: SCCUP; cancer of unknown primary site; local treatment; prognosis; squamous cell carcinoma.

MeSH terms

  • Carcinoma, Squamous Cell* / therapy
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Unknown Primary* / drug therapy
  • Neoplasms, Unknown Primary* / pathology
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome

Grants and funding

This research received no external funding.